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INTRODUCTION
Cervical cancer continues to be an important
women's health problem throughout the world.
Each year nearly 400,000 new cases occur almost
80% in women living in developing countries and at
least 200,000 die of the disease. Globally, cervical
carcinoma is the second most common cancer in
women. In Nigeria and indeed in many parts of sub-
Saharan Africa, cervical carcinoma is the
commonest genital tract cancer. It accounted for
over 60- 80% of all gynaecological cancers, and
its incidence is estimated to be about 25/100,000.
Reports from Europe and America revealed the








the incidence and mortality rates from invasive
carcinoma of the cervix by the detection of
precancerous lesions represented by cervical
intraepithelial neoplasia, and offering appropriate
management. In many parts of developing countries
cervical cancer rates continue to remain unacceptably
high due to lack of effective screening programmes
designed to identify premalignant lesions. Report
from various geographical regions of Nigeria showed
the prevalence rate of CIN to range from 77-120 per
1,000. Many workers in Nigeria have advocated for
a national screening policy/ programme even if it is a
once in a life time screening policy . At present,
opportunistic screening is the rule in many centers
offering cervical screening services, thus identifying
patients/clients at risk of cervical dysplasia will
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Cancer of the cervix is the commonest malignancy of the genital tract in Nigeria. In an atmosphere
of opportunistic screening due to lack of a national screening programme, studies are needed to determine
patients at risk of premalignant lesions of the cervix.
To determine cervical smear pattern in patients with chronic pelvic nflammatory disease and investigate
the potential of chronic pelvic inflammatory disease as a risk factor to cervical dysplasia.
Case- control study.
Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital Zaria,
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Three hundred and sixty-nine premenopausal women attending the gynaecologic and family planning
clinics ofAhmadu Bello University Teaching Hospital Zaria, Nigeria from January to December 2000.
Of the 369 women that had cervical cytology by Pap smear, 163 (44%) had chronic pelvic
inflammatory disease(cases) while 206 (56%) were non chronic PID patients (control). There was no statistical
significance in the mean age between the two groups. The mean age at first coitus and marriage of all the
women were 17.92.7 years and 18.5 3.4 years respectively. There were 52 dysplastic smears encountered, giving
a prevalence rate of 140/1,000 or 14% for Cervical Intraepithelial Neoplasia. There were higher cases of
dysplasia in the chronic PID group than in the control and this differences was statistically significant (p<0.05).
Other risk factors to dysplasia identified include high parity (>4) and age of first coitus less than 20 years. Only
10% of all the women screened were aware of both cervical cancer and Pap smear.
Women with chronic pelvic inflammatory disease are probably at higher risk of developing
cervical dysplasia than women without chronic pelvic inflammatory disease.Cervical cancer screening
programmes should be intensified in chronic pelvic inflammatory disease patients. However, further studies are
needed in our setting to verify the association between pelvic inflammatory disease and cervical dysplasia.
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sexually transmissible infections, unsafe abortions
and puerperal genital infections in many parts of
sub-Saharan Africa including Nigeria , pelvic
inflammatory disease (a common sequelae of the
above conditions) will continue to be a public health
problem in Africa. Also with the polymicrobial
nature of pelvic inflammatory disease (PID)
including viruses such as Human Papilloma Virus
(HPV), women with PID are theoretically at risk of
dysplasia/carcinoma. This study aimed to
document the pattern of cervical smear in patients
with chronic PID and to investigate the potential of
chronic pelvic inflammatory disease as a risk factor
to cervical dysplasia.
This s tudy was a case- control s tudy
(prospective)design that took place from January to
December 2000. Consecutive patients/clients within
the reproductive age, attending the gynecologic and
family planning clinics in Ahmadu Bello University
Teaching Hospital Zaria, Nigeria (ABUTH) during
the period of study were recruited. Patients with
chronic PID were considered 'cases' and those
without chronic PID were considered as 'control'.
For the purpose of this study, chronic pelvic
inflammatory disease was defined and identified as
either of the following:-
(1) Clinically: History of pelvic pain for at least
three months duration associated with vaginal
discharge and with or without deep dyspereunia,
cervical motion or adnexeal tenderness.
(2)Laparoscopic or Laparatomy evidence of PID,
characterized by peritubular and or periovarian
adhesions. Patients with evidence of PID at
caeserean section or laparatomy for ectopic
gestation, smear was done after a minimum period
of 12 and 6 weeks postoperative respectively, to
allow for complete resolution of the effects of
pregnancy.
(3)Radiological (Hysterosalpingogram) evidence of
PID such as hydrosalpinx. Patients who had acute
PID, postmenopausal, yet to commence coitus, and
those with suspicious lesions on the cervix or frank
carcinoma of the cervix were excluded from the
study. Equally excluded from the study were
patients who were pregnant, and patients on post
molar surveillance. Smear from patients with
incomplete or missed abortion were taken after six
weeks post evacuation.
The authors using a standardized questionnaire
interviewed all participants. Clinical and socio-
biological parameters such as age, parity, age of first
coitus and marriage, type of family, number of
sexual partners and social class were noted.
Awareness of cervical carcinoma and Pap smear
were also noted. Each of the patient/client were then
counseled for cervical cytology. Two smears were
15
MATERIALS AND METHOD
taken from each patient. Each patient was placed in the
dorsal position on an examination couch.An
unlubricated bivalve speculum was inserted into the
vagina and a cervical cytology specimen was obtained
with a wooden Arye's Spatula, and immediately fixed
in equal parts of 95% ethyl alcohol and ether. The
smears were then stained by routine Papanicolaou
technique, using Haris Haematoxylin, orange G and
EA50. The stained slides were dried in alcohol,
cleared in xylol and mounted in DPX. An experienced
consultant histopathologist (the fourth author)
interpreted all the smears. The results were grouped
into normal, inflammatory, CIN I/ HPV infection, CIN
II, CIN III, carcinoma in-situ, or invasive carcinoma.
Inadequate smears were repeated after at least two
weeks from the initial smear, and the results grouped
accordingly.
The data was analyzed using EPI-INFO version 6
statistical software. P value for significant was set at
<0.05
From January to December 2000, 369 patients/clients
attending the gynecologic and family planning clinics
of Ahmadu Bello University Teaching Hospital Zaria
satisfied the selection criteria and were screened for
cervical cancer by Papanicolaou smear. One hundred
and sixty-three patients (44.2%) had chronic pelvic
inflammatory disease (PID), while 206 (55.8%) did not
have chronic PID patients (control). Of the 163 patients
with chronic PID, 23.9% were confirmed by
l a p a r o s c o p y / L a p a r a t o m y , 3 . 1 % b y
hysterosalpingograph while 73% were diagnosed
based on clinical grounds only.
The age range of the women screened was 14-
52 years with a mean age of 31.7 years 7.6 years. The
mean age for the chronic PID group was 30.8 7.1
years, while that of the control group was 32.3 8.0
years. The difference in the mean value of the two
groups is not statistically significant (Pvalue= 0.490).
Eighty-nine percent of the women screened were
married while six, three and two percent were single,
divorced and widowed respectively. Ninety-four
percent of all the women screened were married at
some point. The minimum age at first marriage was 12
years and maximum was 35 years, with a mean age at
first marriage of 18.5 3.4 years. The mean age of first
marriage for the subjects (chronic PID group) was 18.4
years while that of control was 18.6 years. The
difference was not significant (P value=0.345). 73% of
the women screened were married once while 17.3%
were in their second order of marriage. Only 9% had
married thrice or more. 38.5% of the married women
were in polygamous union. The mean age at first coitus
in the study population was 17.9 2.7 years. 252
Data Analysis
RESULTS
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Table1:
X2= 32.67 df=4 P value = 0.157
CIN = Cervical intraepithelial Neoplasia
HPV = Human Papilloma Virus.
Table2:
X2= 27.88 df=4 Pvalue = 0.0035
CIN = Cervical intraepithelial Neoplasia.
Table 3:
X = 39.59,df=3, Pvalue=0.0015
HPV = Human PapillomaVirus
CIN = Cervical intraepithelial Neoplasia
PID = Pelvic inflammatory disease.
Age Group Distribution of Women
Screened with Pap smear Results.
Age Specific Group Distribution of
Dysplasia (CIN) between Cases and Controls.
Pap smear Result in Patients with Chronic
Pelvic Inflammatory Disease and Control.
2
Age Group (years) Dysplastic smears
Cases Control
Total
19 - - -
20-29 7 5 12
30-39 15 8 23
40-49 9 5 14
50-59 2 1 3
Total 33 19 52
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women (68.3%) commenced coitus before the age of
20 years. The minimum age at first coitus was 12
years and the maximum age was 33years. Seventy-
three percent of the women screened had a single
sexual partner while 27% had two or more sexual
partners. This is against a background polygamous
rate of 38.5% encountered in this study. Only 10% of
women in this study belonged to high social class
that is tertiary education and (or their spouses)
skilled occupation while 38% and 52% belong to the
middle and low social class respectively. Sixty-eight
percent of the women screened were of parity four or
less while 32% were grandmultiparas. Of the 369
women screened, only 30% had ever heard of
cervical cancer and a mere 11% were even aware of
Pap smear for cervical cancer screening. The
hospital was the main source of their awareness,
accounting for 57%, followed by friends and or
relations (25%). Only 13% of women derived their
knowledge of cervical cancer/Pap smear from the
electronic /print media.
Table 1 and 2 shows the age group distribution with
all Pap smear result and specifically for CIN
respectively. There were 52 dysplastic smears
encountered in this study giving a prevalence rate of
141/1,000 or 14% and a mean age of 37.5± 8.3yrs
years for CIN. There were more dysplastic smears in
cases than in control in all the age groups and this
was statistically significant. The 50-59 years age
group shows the highest prevalence rate (60%).
Table3 and 4 reveals all Pap smears and dysplastic
smears distribution among 'cases' and 'control'
respectively. Inflammatory, HPV associated changes
/ dysplasia were higher in the chronic PID group than
the control. This difference was significant (p<0.05).
Of the 52 dysplastic smears, 33 (63.5%) were in
patients with chronic PID while 19 (36.5%) were in
the control group. This difference was statistically
significant (X =29.01, df=4, P value= 0.0025, Odds
Ratio= 1.7). Forty-five cases of CIN (86.5%) were
seen in women who had their first coitus before 20
years(n=252) while 7 or 18.5% were seen in women
who had their first sexual experience at or above
20years(n=117). This difference in proportion was
statistically significant (X =27.8, df=3, P
value=0.013). Fifty-eight percent of women with
dysplasia were of parity >4(n=118) while the
remaining 42% or 22 were of parity 4(n=251). The
















19 6 11 - - - 17(4.6%)
20-29 79 50 10 1 1 141
(38.2%)
30-39 68 56 18 5 1 148
(40.1%)
40-49 21 24 7 2 4 58
(15.7%)
50-59 - 2 3 - - 5 (1.3%)
Total 174 143 38 8 6 369
Smear Result Chronic PID Non-chronic
PID (Control)
Total
Normal/Negative 50 124 174
Inflammatory 80 63 143
CIN I /HPV Infection 23 15 38
CIN II 6 2 8
CIN III 4 2 6
Total 163 206 369
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smear/cancer of the cervix and utilization of screening
services in this study is similar to established data in
Nigeria. The need for intensive and sustained
public health education on cervical cancer and its
prevention need not be overemphasized.
Estimates of the
worldwide incidence of eighteen major cancers in
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Table 4:
X =29.01, df=4, Pvalue= 0.0025
CIN = cervical intraepithelial Neoplasia
PID = Pelvic inflammatory Disease
The prevalence rate of 141/1,000 or 14% Cervical
Intraepithelial Neoplasia encountered in this study is
remarkable. It is much higher than the rate of
77/1,000 reported from Jos, 120/1,000 reported
from Ondo, 110/1,000 reported from Enugu and
43.5/1,000 from Yaounde, Cameroon and 11.8% in
Ibadan. This may partly be due the small sample
size in this study, exclusion of postmenopausal
women in this study and partly because of the
different socio-demographic structure particularly
the high polygamous rate of 39% in our study
population.The significant differences in the
prevalence of dysplasia among patients with chronic
pelvic inflammatory disease compared to those
without chronic PID, revealed the potential of
chronic PID as a risk factor to cervical dysplasia.
This finding seems to be in agreement to the
observation of Anorlu and colleaques that
prevalence of abnormal cervical smears is high in
patients with genital tract disease. It is probable that
PID patients are more likely to be infected with
Human papilloma virus than non-PID patients. Also
the cervicitis which is usually associated with PID,
may damage the defensive barrier mechanisms of
the cervical epithelium and thus faclitate HPV
associated changes resulting in dysplasia
/carcinoma. Hence screening programmes in this
group of patients should be intensive. Further studies
are needed to determine the true association between
PID and cervical dysplasia. The higher number of
cases of dysplasia among grandmultiparous patients
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this study is consistent with established data. Also
consistent with existing knowledge is the
observation of higher cases of dysplasia in patients
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